Digital Twins and AI-Driven Drug Discovery
This week in the Guardrail, we break down how predictive AI models and clinical digital twins are accelerating time to market, streamlining regulatory filings, and reshaping early-phase trial architecture.
This week in the Guardrail, we break down how predictive AI models and clinical digital twins are accelerating time to market, streamlining regulatory filings, and reshaping early-phase trial architecture.